Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Cancer Discovery|July 1, 2024
Targeted Bias: The Next Swing at IL2 TherapyKayla R Kulhanek, Anusha KalbasiNature Reviews. Immunology|October 2, 2019
Tumour-intrinsic resistance to immune checkpoint blockadeAnusha Kalbasi, Antoni RibasClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2018
Antigen Presentation Keeps Trending in Immunotherapy ResistanceAnusha Kalbasi, Antoni RibasTranslational Lung Cancer Research|May 23, 2017
Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanomaAnusha Kalbasi, Ramesh RenganMethods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Regulation of the Small GTPase Ras and Its Relevance to Human DiseaseKayla R Kulhanek, Jeroen P Roose, Ignacio RubioAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2020
How Technology Is Improving the Multidisciplinary Care of SarcomaInga-Marie Schaefer, Kelvin Hong, Anusha KalbasiJournal of Oncology Practice|March 11, 2017
Functio Laesa: Cancer Inflammation and Therapeutic ResistanceMingen Liu, Anusha Kalbasi, Gregory L BeattyThe Journal of Clinical Investigation|July 19, 2013
Radiation and immunotherapy: a synergistic combinationAnusha Kalbasi, Carl H June, Naomi Haas, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic proteinAnusha Kalbasi, Rajeev K Shrimali, Dhanalakshmi Chinnasamy, et al.Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.Pageof 8